For Ontario life sciences companies that have moved beyond R&D and are ready to scale, the challenge often shifts to manufacturing, commercialization, and preparing for real-world healthcare adoption. The Life Sciences Scale-Up Fund was created to help address that gap, offering meaningful financial support to small and medium-sized biotech and life sciences businesses that are ready to expand operations and compete at a global level.
Delivered by the Ontario Ministry of Economic Development, Job Creation and Trade, this fund focuses on market-ready innovations that can strengthen the province’s healthcare supply chain. Support can reach up to roughly $2 million per project and is provided as a non-repayable contribution, typically covering about one-third of eligible expansion costs. Projects often include scaling domestic manufacturing, commercializing healthcare products, or positioning a company to respond to public-sector procurement opportunities. The program is especially relevant for businesses that already have traction and financing in place but need support to accelerate growth and adoption.
The Life Sciences Scale-Up Fund has also been designed to work alongside other health innovation initiatives in Ontario, helping build a stronger pipeline of competitive, homegrown companies. Availability and intake periods can change, so understanding the current status, project fit, and funding structure is key. Reviewing the full details through GrantHub can help determine whether this opportunity aligns with your scale-up plans.
Was this guide helpful?
Rate it so we can improve our content.
Canada Proactive Disclosure Data
The Canadian government has funded over 400,000 businesses through 1.27 million grants and contributions. Check your eligibility in 60 seconds.